The global point-of-care diagnostics market is anticipated to reach USD 18.7 billion by 2020, according to a new report by Grand View Research, Inc. Growing developments in the field of decentralized diagnosis and supportive reimbursement policies are expected to propel this industry growth in the next six years.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry
Further key findings from the report suggest:
·
Rising prevalence of chronic disorders and
infectious diseases, which need portable and rapid diagnosis, is anticipated to
boost this technology growth. Introduction of advanced diagnostic techniques
such as utilization of efficient algorithms for diagnosis with specificity and
sensitivity in order to aid prognosis by providing precise view of disease
progression is expected to fuel this sector growth in the next six years.
·
Blood testing segment accounted for majority of
the market share with the revenue of over USD 4 billion in 2013. Key factors
attributing for its high revenue share include increase in prevalence of
diabetes and comparatively higher availability of handheld products for blood
glucose monitoring across the globe.
·
Infectious diseases segment is expected to
register the fastest growth at a CAGR of over 6.0% in the next seven years
owing to the higher prevalence of chronic infectious diseases including
HIV/AIDS, tuberculosis, hepatitis, and HPV. Rise in health awareness levels and
technological advancements in this segment are expected to fuel segment growth
in future.
·
North America was observed to be the dominant
region for POC diagnostics industry accounting for over 40% of the global
revenue in 2013 owing to the presence of encouraging reimbursement frameworks
and the introduction of federal guidelines for diagnostics tests.
·
Asia Pacific POC diagnostics sector is expected
to grow at a lucrative rate from 2014 to 2020 and its market is estimated to
reach over USD 5,300 million in 2020. Presence of high unmet medical needs,
rise in disposable income, and improvement in healthcare infrastructure in
emerging economies of this region are the factors that are expected to drive
growth in this region.
·
Major players of this sector include Siemens Healthcare,
Abbott Laboratories, Danaher Corporation, Roche Diagnostics, Beckman Coulter
Inc., and Becton Dickinson & Company. This industry is competitive in
nature marked by high industry rivalry levels. Players are adopting strategies
such as collaborations with hospitals and healthcare institutes to maintain
their position. Furthermore, companies in this sector are also involved in
strategic mergers with smaller entities operating in the international markets
to enhance their global geographic presence.
Browse All Reports of
this category @ http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented
the global point of care diagnostics market on the basis of product, end-user
and region:
Point of Care Diagnostics Product
Outlook
- Blood Gas/Electrolytes (Centralized and Decentralized)
- Infectious Diseases
- Hospital Glucose Testing
- Cardiac Markers
- Hematology
- Coagulation
- Primary Care Systems (Lipid Profiling and HbA1c Tests)
- Decentralized Clinical Chemistry
- Urinalysis
- Drug Abuse Testing
- Fertility
- OTC and Rapid Diagnostic Tests
Point of Care Diagnostics End User
Outlook
- Hospitals
- Assisted Living Healthcare Facilities
- Laboratories
- Home
- Clinics
- Others
Point of Care Diagnostics Regional
Outlook
- North America
- Europe
- Asia Pacific
- RoW
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry
James
Corporate
Sales Specialist, U.S.A.
Grand
View Research, Inc.
United
States
Phone: 1-415-349-0058
Toll
Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Blog
Site: http://www.divog.org/
